proteas
enzym
hydrolyz
peptid
bond
within
endogen
substrat
peptid
play
key
role
regul
mani
physiolog
condit
proteas
activ
dysregul
mani
diseas
includ
cancer
diabet
neurolog
disord
date
five
major
famili
abbrevi
aat
abu
aminobutyr
acid
abp
activitybas
probe
abz
aminobenzo
acid
acc
act
antichymotrypsin
amc
aomk
acyloxymethylketon
catg
cathepsin
g
clip
cellular
librari
peptid
substrat
cosesul
counter
select
substrat
librari
dub
deubiquityl
enzym
gr
granzym
hk
human
kallikrein
hleu
homoleucin
hycosul
hybrid
combinatori
substrat
librari
iqf
intern
quench
fluoresc
substrat
leukotrien
hydrolas
mucosaassoci
lymphoid
tissu
lymphoma
transloc
protein
met
methionin
sulfon
mmp
matrix
metalloproteinas
ne
neutrophil
elastas
nle
obzl
acid
nle
norleucin
neutrophil
serin
proteinas
nsp
neutrophil
serin
proteas
oic
acid
pal
pyridyllalanin
proteinas
psa
prostatespecif
antigen
psscl
posit
scan
synthet
combinatori
librari
sar
structur
activ
relationship
sa
substrat
activ
screen
senp
human
desumoyl
enzym
tic
acid
uch
ubiquitin
ctermin
hydrolas
proteas
describ
serin
cystein
metallo
aspartyl
threonin
proteas
fig
abund
explor
famili
serin
cystein
proteas
name
reactiv
nucleophil
group
activ
sitesth
hydroxyl
group
serin
thiol
group
cystein
mechanist
proteas
hydrolyz
peptid
bond
substrat
endopeptidas
n
c
termini
exopeptidas
proteinas
belong
famili
caspas
neutrophil
serin
proteas
aminopeptidas
cathepsin
kallikrein
typic
similar
function
process
natur
occur
substrat
howev
littl
known
individu
physiolog
pathophysiolog
function
proteas
answer
question
chemic
tool
includ
substrat
inhibitor
activitybas
probe
abp
becom
essenti
monitor
chang
activ
proteolyt
enzym
cell
even
whole
organ
fig
despit
signific
progress
recent
year
one
greatest
challeng
design
test
substrat
inhibitor
abp
achiev
specif
toward
one
enzym
specif
particularli
import
enzym
presenc
enzym
similar
catalyt
mechan
complet
differ
function
crossreact
substrat
inhibitor
abp
enzym
significantli
impair
even
prevent
investig
target
proteas
specif
substrat
inhibitor
abp
proteolyt
enzym
optim
select
appropri
amino
acid
sequenc
interact
bind
pocket
proteas
mani
differ
approach
propos
use
investig
substrat
specif
includ
posit
scan
synthet
combinatori
librari
psscl
phage
display
hybrid
combinatori
substrat
librari
hycosul
counter
select
substrat
librari
cosesul
intern
quench
fluoresc
substrat
iqf
librari
also
call
fluoresc
reson
energi
transfer
librari
proteom
vari
result
fig
first
broad
chemic
approach
studi
proteas
substrat
specif
propos
thornberri
colleagu
concept
psscl
fig
substrat
librari
compris
three
sublibrari
studi
proteas
prefer
posit
instanc
sublibrari
posit
fix
one
natur
amino
acid
posit
random
equimolar
mixtur
natur
amino
acid
make
librari
use
studi
variou
caspas
posit
occupi
amc
caspas
specif
prefer
activ
site
pocket
obtain
screen
posit
separ
make
approach
posit
profil
shortli
ellman
craik
group
util
bifunct
acc
fluorophor
report
group
psscl
make
introduc
variou
amino
acid
posit
much
effortless
date
proteas
profil
psscl
approach
rank
technolog
among
use
tool
proteas
substrat
specif
investig
howev
tradit
psscl
demonstr
insuffici
analyz
proteas
overlap
substrat
specif
profil
eg
caspas
cystein
cathepsin
neutrophil
proteas
deubiquityl
enzym
dub
use
natur
amino
acid
psscl
reduc
chanc
find
specif
andor
activ
peptid
toward
proteas
interest
drawback
overcom
novel
approach
develop
drag
laboratori
concept
hycosul
reli
use
broad
panel
unnatur
amino
acid
substrat
sequenc
explor
proteas
activ
site
much
accur
set
natur
analogu
alon
fig
use
unnatur
amino
acid
fluorogen
substrat
librari
also
appli
cosesul
approach
restrict
proteas
display
broad
substrat
specif
one
activ
site
pocket
compar
specif
matrix
proteas
display
narrow
specif
correspond
pocket
becom
possibl
distinguish
enzym
psscl
hycosul
cosesul
valuabl
tool
studi
proteas
substrat
specif
howev
limit
nonprim
pocket
enzym
activ
site
iqf
substrat
offer
excel
platform
studi
proteas
prefer
prime
nonprim
region
fig
brief
iqf
substrat
peptid
variou
length
flank
fluoresc
group
donor
quencher
group
acceptor
intact
peptid
quench
state
fluoresc
donor
quench
appropri
acceptor
peptid
cleav
proteas
peptid
fragment
fluorophor
separ
quencher
fluoresc
liber
current
singl
unifi
technolog
use
iqf
substrat
proteas
screen
architectur
iqf
substrat
librari
tailor
proteas
investig
date
variou
donoracceptor
pair
describ
literatur
review
elsewher
altern
chemicalbas
approach
phage
display
technolog
biolog
origin
also
extens
develop
studi
proteolyt
enzym
methodolog
pioneer
smith
express
divers
pool
peptid
surfac
bacteriophag
techniqu
initi
orient
studi
proteinprotein
interact
howev
later
modifi
adapt
proteas
substrat
specif
profil
fig
main
advantag
phage
display
gener
larg
divers
pool
substrat
individu
peptid
would
challeng
chemic
synthesi
anoth
import
featur
techniqu
peptid
subject
proteas
analysi
round
expressionselect
thu
subsequ
cycl
peptid
increas
qualiti
gener
one
main
drawback
method
peptid
labelfre
therefor
kinet
analysi
best
substrat
requir
peptid
resynthes
appropri
report
group
sinc
matthew
well
first
describ
use
phage
display
proteas
screen
multipl
enzym
profil
techniqu
review
describ
import
concept
latest
challeng
focus
mainli
peptidebas
chymotrypsinlik
neutrophil
serin
proteas
primari
granul
neutrophil
serin
proteas
nsp
primari
granul
abund
serin
proteas
present
almost
organ
nsp
famili
includ
neutrophil
elastas
ne
cathepsin
g
catg
proteinas
neutrophil
serin
proteinas
among
other
enzym
involv
kill
bacteria
via
format
neutrophil
extracellular
trap
nsp
evolv
common
ancestor
gene
duplic
reveal
new
branch
chymotrypsinogen
superfamili
serin
proteas
nsp
consist
five
exon
four
intron
along
gene
ne
gene
lie
chromosom
outsid
cluster
catg
locat
chromosom
regard
primari
structur
amino
acid
residu
determin
substrat
recognit
site
nsp
quit
similar
catalyt
residu
substratebind
pocket
locat
crevic
two
bbarrel
therefor
enzym
share
similar
catalyt
prefer
recogn
endogen
inhibitor
belong
serpin
serin
proteas
inhibitor
famili
antitrypsin
proteinas
inhibitor
human
monocyteneutrophil
elastas
inhibitor
inhibit
ne
catg
chemic
nsp
divid
group
ne
recogn
small
aliphat
amino
acid
residu
val
ala
posit
catg
recogn
bulki
hydrophob
aliphat
aromat
amino
acid
phe
leu
sometim
arg
restrict
arg
ne
also
overlap
primari
substrat
specif
therefor
specif
substrat
inhibitor
activitybas
probe
report
enzym
mani
year
specif
issu
confirm
eleg
approach
toward
global
identif
neutrophil
proteas
specif
recent
describ
odonoghu
et
al
method
rapid
multiplex
substrat
profil
analysi
use
liquid
chromatographytandem
mass
spectrometri
sequenc
appli
profil
substrat
neutrophil
serin
proteas
human
neutrophil
extracellular
trap
obtain
data
clearli
show
enzym
overlap
yet
distinct
endopeptidas
activ
suggest
overlap
function
substrat
prefer
neutrophil
serin
proteas
recent
lesner
group
report
design
synthesi
intern
quench
iqf
substrat
structur
abztyrtyrabuasngluprotyr
nh
enzym
catalyt
effici
k
cat
k
k
cat
k
valu
ne
calcul
use
substrat
drag
colleagu
enrich
classic
psscl
broad
rang
unnatur
amino
acid
approach
known
hycosul
fig
technolog
allow
research
explor
bind
site
variou
structur
surprisingli
contrast
previous
known
ne
substrat
sequenc
acaapvamc
fig
hycosul
screen
identifi
bulki
acid
nle
obzl
residu
result
confirm
later
lechtenberg
present
crystal
structur
ne
abp
contain
nle
obzl
posit
demonstr
fit
unnatur
amino
acid
enzym
pocket
activ
site
moreov
methionin
sulfon
met
identifi
site
suggest
potenti
posttransl
modif
natur
ne
substrat
surprisingli
ne
acid
oic
prefer
prolin
deriv
posit
crucial
comparison
k
cat
k
valu
synthes
substrat
ne
show
acnl
obzl
met
oicabuacc
fig
substrat
approxim
specif
ne
compar
exhibit
rel
small
k
lm
ne
abp
neutrophil
elastas
base
optim
ne
sequenc
use
vitro
studi
allow
research
discrimin
ne
monitor
activ
neutrophil
elastas
neutrophil
trap
first
time
catg
bear
dual
chymotrypsinand
trypsinlik
substrat
specif
due
shape
pocket
catg
hydrolyz
peptid
bond
phe
less
potenc
arg
therefor
enzym
might
crossreact
substrat
kasperkiewicz
et
al
use
hycosul
technolog
search
molecul
investig
primari
specif
use
technolog
specif
substrat
abp
synthes
test
vitro
assay
recogn
larg
hydrophob
residu
posit
homocyclohexylalanin
larg
basic
residu
prolin
deriv
oic
posit
fig
success
substrat
potent
k
cat
k
approxim
specif
compar
catg
discoveri
prompt
synthesi
abp
result
first
coval
bind
abp
exhibit
approxim
specif
bind
compar
catg
nsp
involv
mani
diseas
particularli
diseas
associ
lung
thu
consid
valuabl
drug
target
moreov
drug
trial
conduct
discrimin
serin
proteas
use
inhibitor
although
inhibitor
use
clinic
trial
date
one
compound
sivelestat
ono
pharmaceut
approv
use
drug
competit
inhibitor
specif
ne
trypsin
thrombin
chymotrypsin
catg
plasmin
rel
small
halfmaxim
inhibitori
concentr
ic
nm
k
lm
toward
ne
bestknown
vitro
serin
proteas
inhibitor
peptidyl
deriv
aaminoalkylphosphon
diphenyl
ester
coval
inhibitor
bind
hydroxyl
group
serin
activ
site
compound
mimic
natur
amino
acid
frequent
use
ne
inhibitor
vitro
studi
oleksyszyn
colleagu
modifi
ester
inhibitor
class
subsequ
found
smethylsulfodiphenyl
diester
potent
unmodifi
ester
unfortun
approach
suffici
distinguish
ne
recent
guarino
et
al
design
di
chlorophenyl
phosphon
ester
character
unexpect
structur
contain
asp
posit
instead
pro
describ
bestfit
amino
acid
pocket
use
probe
peg
aminoomegacarboxi
poli
ethylen
glycol
linker
biotin
tag
character
rel
small
secondord
inhibit
constant
k
ob
proteinas
show
weak
bind
ne
probe
detect
permeabil
neutrophil
author
suggest
probe
may
use
monitor
detect
control
activ
inflammatori
diseas
howev
control
perform
human
granzym
gr
name
granul
enzym
masson
tschopp
close
relat
proteas
nucleophil
serin
residu
stabil
histidin
aspart
acid
enzym
activ
site
express
cytotox
lymphocyt
natur
killer
nk
cell
proteas
pack
cytoplasm
granul
similarli
nsp
secret
stimul
human
five
gr
distinguish
b
h
k
howev
granzym
gene
found
three
chromosom
three
cluster
gra
grb
grm
cluster
gra
cluster
chromosom
includ
gra
grk
grb
cluster
chromosom
includ
grb
grh
grm
cluster
chromosom
includ
grm
gr
share
distinct
structur
featur
presenc
signal
peptid
prodipeptid
remov
activ
although
subtl
differ
crystal
structur
gr
detect
remain
challeng
similar
instanc
antigrb
bind
gra
grh
problem
magnifi
sinc
shown
gr
recogn
cleav
natur
substrat
instanc
gra
substrat
report
grb
substrat
well
among
cleavag
site
date
specif
tool
distinguish
activ
inact
gr
found
howev
eleg
approach
publish
discuss
review
gra
abund
granzym
effect
gra
k
caspaseindepend
cell
death
remain
unclear
thu
necessari
distinguish
enzym
understand
individu
role
gra
k
primarili
act
inflamm
promot
secret
cytokin
interleukin
tumor
necrosi
factor
enzym
recogn
natur
substrat
extend
substrat
specif
enzym
almost
ident
enzym
recogn
tyr
asp
val
posit
phe
pro
posit
asp
met
posit
grk
also
recogn
leu
phe
trp
posit
prefer
glu
gln
result
reveal
substanti
differ
gra
k
particularli
subsit
differ
substrat
cleav
enzym
vitro
identifi
gra
k
might
differ
physiolog
function
van
damm
et
al
also
explor
identifi
gra
substrat
prefer
use
proteom
approach
similar
result
util
proteom
granzym
specif
determin
review
elsewher
granzym
b
grb
known
serin
proteas
restrict
specif
asp
posit
featur
common
caspas
belong
cystein
proteas
famili
grb
caspas
similar
key
function
includ
induct
apoptosi
although
belong
differ
proteas
famili
differ
evolutionari
origin
harri
colleagu
analyz
extend
substrat
specif
grb
use
filament
phage
display
explor
posit
librari
one
defin
posit
site
fix
base
result
grb
recogn
glu
posit
gli
posit
unlik
gra
k
grm
h
differ
prefer
posit
therebi
facilit
differenti
sever
method
use
studi
grm
h
includ
posit
scan
librari
coumarin
substrat
well
screen
individu
pnitroanilid
coumarin
substrat
grm
hydrolyz
peptid
bond
aliphat
amino
acid
ile
met
hydrolyz
bond
phe
grh
also
prefer
hydrophob
amino
acid
posit
includ
phe
hydrolyz
peptid
bond
met
power
colleagu
use
seri
peptid
thiobenzyl
ester
determin
primari
specif
grm
exhibit
prefer
pro
ala
ser
asp
posit
use
psscl
mahru
et
al
explor
subsit
show
substrat
specif
profil
two
librari
similar
posit
slightli
differ
posit
might
effect
subsit
cooper
studi
extend
specif
also
conduct
mahru
et
al
use
psscl
approach
analyz
grm
k
h
b
identifi
differ
substrat
prefer
allow
investig
specif
inhibitor
abp
summari
peptid
sequenc
granzym
identifi
use
psscl
phage
display
proteom
aid
futur
research
discrimin
individu
physiolog
function
van
damm
group
perform
hierarch
cluster
surfac
surround
granzym
activ
site
use
proteom
confirm
observ
base
chemic
method
pocket
restrict
bind
asp
grb
arg
gra
k
metleu
grm
phe
grh
pocket
bind
broad
rang
amino
acid
residu
due
subtl
differ
primari
specif
profil
howev
research
necessari
distinguish
among
granzym
particularli
gra
k
human
tissu
kallikrein
famili
compris
least
serin
proteas
encod
largest
proteas
gene
cluster
express
almost
everi
tissu
includ
brain
breast
skin
among
other
enzym
possess
least
sequenc
ident
similar
molecular
size
kda
chymo
trypsin
specif
debela
et
al
determin
extend
substrat
specif
seven
human
tissu
kallikrein
antigen
psa
use
combinatori
peptid
librari
base
data
show
chymotrypsintrypsinlik
activ
hydrolyz
peptid
bond
larg
hydrophob
tyr
aliphat
ala
nle
polar
amino
acid
arg
ly
kallikrein
exhibit
trypsinlik
specif
strong
prefer
wherea
display
dual
specif
hydrolyz
peptid
bond
aliphat
nle
met
ala
basic
amino
acid
residu
ly
arg
investig
enzym
demonstr
broad
specif
subsit
recogn
pro
recogn
asp
investig
kallikrein
demonstr
subtl
differ
posit
similar
substrat
specif
psscl
result
agre
structur
data
therefor
might
help
futur
research
howev
specif
substrat
select
kallikrein
synthes
character
use
promis
specif
profil
thu
subsit
cooper
exclud
addit
valid
necessari
nevertheless
present
data
valuabl
preliminari
result
psa
display
sequenc
ident
hinder
develop
specif
substrat
inhibitor
antibodi
enzym
wu
et
al
use
cyclic
phage
display
peptid
librari
identifi
peptid
specif
activ
psa
serin
proteas
includ
chymotrypsin
catg
kallikrein
trypsin
identifi
sequenc
bind
activ
site
psa
allow
us
distinguish
activ
inact
psa
contrast
antibodi
label
bind
form
wu
colleagu
use
discoveri
develop
new
immunopeptidometr
assay
uniqu
specif
addit
hekim
et
al
use
phage
display
identifi
specif
sequenc
peptid
inhibitor
approach
librari
use
peptid
bind
isol
specif
cyclic
peptid
substrat
inhibitori
activ
linear
peptid
inhibitor
rfkxww
arrpxp
overlap
specif
toward
psa
chymotrypsin
variou
trypsin
isoenzym
obtain
peptid
differenti
psa
previous
possibl
anoth
approach
de
veer
et
al
use
spars
matrix
librari
consist
defin
peptid
explor
substrat
specif
grsr
yrsr
grnr
report
activ
sequenc
inhibitor
subsequ
engin
substitut
substrat
sequenc
bind
loop
residu
sunflow
trypsin
howev
despit
high
activ
design
inhibitor
lack
select
author
substitut
residu
gener
specif
inhibitor
kinet
constant
k
ae
nm
inhibitor
display
low
activ
toward
select
one
interest
success
approach
investig
specif
molecul
kallikrein
describ
cloutier
et
al
felber
et
al
group
use
strategi
modifi
serpin
endogen
inhibitor
serin
proteas
reactiv
center
loop
crucial
inhibit
serin
proteas
amino
acid
near
scissil
bond
reactiv
center
loop
modifi
anoth
approach
extract
structur
fragment
obtain
specif
recombin
inhibitor
approach
phage
display
methodolog
use
select
peptid
sequenc
six
variant
two
variant
dual
chymo
trypsinlik
substrat
specif
felber
et
al
describ
four
variant
recombin
mutant
serpin
two
variant
serpin
aat
antichymotrypsin
act
act
aat
five
residu
surround
scissil
bond
replac
pentapeptid
sequenc
previous
obtain
use
phage
display
specif
test
enzym
broad
rang
specif
elastas
chymotrypsin
trypsin
plasma
kallikrein
thrombin
test
enzym
belong
famili
ie
one
two
variant
act
aat
display
select
except
chymotrypsin
variant
specif
inhibit
two
actderiv
inhibitor
form
stabl
complex
contrast
aat
inhibitor
sequenc
insert
act
result
inhibitor
screen
human
neutrophil
elastas
well
proteas
chymotrypsinlik
chymotrypsin
psa
trypsinlik
plasma
kallikrein
urokinasetyp
plasminogen
activ
activ
two
variant
modifi
act
retain
specif
activ
use
clever
mix
strategymodif
reactiv
center
loop
serpin
differ
peptid
sequenc
author
abl
distinguish
broad
rang
serin
proteas
except
chymotrypsin
caspas
cystein
proteas
display
narrow
prefer
posit
primarili
recogn
aspart
acid
except
primari
specif
quit
rare
among
proteas
howev
well
colleagu
recent
shown
enzym
also
cleav
substrat
glutam
acid
phosphoserin
residu
shed
new
light
physiolog
function
sinc
discoveri
character
caspas
year
ago
hundr
paper
publish
substrat
inhibitor
unfortun
exclus
specif
asp
posit
make
difficult
distinguish
enzym
use
psscl
tool
thornberri
colleagu
determin
substrat
prefer
pocket
nine
human
caspas
base
profil
caspas
divid
three
group
prefer
wl
ehd
sequenc
recogn
de
v
h
peptid
favor
vl
ehd
motif
nevertheless
specif
matrix
clearli
show
proteas
display
overlap
substrat
specif
optim
sequenc
propos
author
may
specif
one
enzym
inde
later
work
group
shown
short
inher
substrat
contain
tetrapeptid
motif
display
crossreact
among
caspas
make
difficult
use
substrat
cell
extract
contain
differ
concentr
sever
caspas
anoth
approach
design
caspasespecif
substrat
stennick
colleagu
synthes
panel
iqf
substrat
fig
strategi
also
allow
author
screen
caspas
prefer
prime
region
ie
right
scissil
bond
kinet
analysi
reveal
test
caspas
prefer
small
residu
gli
ser
ala
could
use
discrimin
factor
improv
specif
synthes
substrat
inabl
design
caspasespecif
substrat
use
psscl
approach
scan
intern
quench
substrat
could
due
simpl
architectur
chemic
approach
substrat
short
linear
peptid
select
pool
peptid
mixtur
without
indepth
caspas
subsit
cooper
analysi
biolog
approach
repres
altern
strategi
substrat
identif
one
strategi
test
caspas
applic
cellular
librari
peptid
substrat
clip
develop
boulwar
et
al
potenti
caspas
substrat
randomli
synthes
bacteria
subject
fluorescenceactiv
cell
sort
analysi
techniqu
provid
gener
map
caspas
prefer
also
reveal
detail
kinet
analys
substrat
howev
obtain
result
confirm
prefer
cleavag
motif
dxvdg
new
specif
sequenc
identifi
main
limit
describ
method
use
synthet
natur
substrat
peptid
contain
natur
amino
acid
structur
potenti
solut
approach
recent
propos
poreba
et
al
hycosul
approach
peptid
mixtur
enrich
unnatur
amino
acid
provid
better
explor
chemic
space
caspas
activ
site
attenu
issu
overlap
specif
specif
six
human
apoptot
caspas
toward
posit
screen
use
approach
detail
kinet
analysi
prefer
allow
develop
peptid
contain
unnatur
amino
acid
much
greater
select
indic
previous
report
substrat
fig
one
substrat
use
specif
monitor
activ
cytosol
extract
apoptosi
trigger
cytochrom
c
anoth
challeng
issu
distinguish
caspas
develop
specif
inhibitor
potent
select
caspas
inhibitor
appear
potenti
drug
candid
area
research
explor
rigor
identif
caspas
substrat
date
thousand
caspas
inhibitor
synthes
evalu
caspas
inhibitor
synthes
use
studi
apoptosi
vitro
vivo
wherea
other
primarili
use
pharmaceut
research
gener
almost
strategi
develop
caspasespecif
inhibitor
focu
optim
peptid
peptidomimet
scaffold
nonprim
region
b
explor
pocket
introduc
variou
warhead
cystein
trap
pssclderiv
peptid
mostli
devd
ietd
yvad
c
optim
lead
nonpeptid
scaffold
structur
isatin
indolon
quinolin
previou
studi
synthet
caspas
inhibitor
simpl
peptid
equip
electrophil
warhead
eg
acyloxymethylketon
aomk
fluoromethyl
keton
aldehyd
peptid
motif
base
psscl
result
report
thornberri
et
al
howev
tool
subsequ
shown
display
limit
select
toward
individu
caspas
inclus
natur
amino
acid
posit
produc
specif
inhibitor
unnatur
amino
acid
introduc
peptid
scaffold
work
pioneer
bogyo
colleagu
synthes
combinatori
librari
aomk
inhibitor
contain
unnatur
amino
acid
posit
approach
appli
wolan
colleagu
synthes
peptid
librari
contain
aldehyd
electrophil
warhead
introduct
unnatur
amino
acid
peptid
sequenc
result
increas
inhibitor
select
chemic
approach
develop
caspasespecif
inhibitor
abp
recent
review
poreba
et
al
mucosaassoci
lymphoid
tissu
lymphoma
transloc
protein
paracaspas
belong
cystein
proteas
famili
contain
domain
homolog
caspas
henc
defin
dixit
et
al
paracaspas
along
caspas
belong
cd
clan
catalyt
hisci
diad
characterist
caspas
date
report
describ
substrat
probe
probe
use
jurkat
cell
extens
select
studi
toward
enzym
perform
interestingli
probe
propos
xin
et
al
bind
signal
also
observ
therefor
need
distinguish
proteas
share
arg
specif
necessari
determin
precis
substrat
specif
design
optim
substrat
inhibitor
salvesen
group
use
psscl
identifi
interest
featur
narrow
specif
posit
hydrolyz
leu
arg
respect
broad
specif
find
help
design
abp
enzym
howev
abp
contain
natur
amino
acid
residu
specif
toward
proteas
remain
unclear
might
benefici
use
unnatur
amino
acid
optim
probe
reduc
potenti
crossreact
proteolyt
enzym
similar
caspas
cathepsin
group
cystein
proteas
display
overlap
substrat
specif
broad
studi
substrat
prefer
enzym
first
describ
choe
et
al
use
psscl
approach
dissect
substrat
specif
six
human
cystein
cathepsin
l
v
k
f
b
six
cathepsin
exhibit
similar
substrat
prefer
signific
differ
cathepsin
k
recogn
pro
wherea
cathepsin
distinguish
featur
suffici
develop
cathepsin
kspecif
tetrapeptid
substrat
hydrolyz
famili
member
howev
aomk
inhibitor
sequenc
display
offtarget
activ
also
inhibit
cathepsin
b
anoth
strategi
rapid
develop
cathepsin
substrat
substrat
activ
screen
sa
propos
patterson
et
al
method
librari
aminocoumarin
deriv
variou
nacyl
group
screen
activ
cathepsin
activ
substrat
convert
inhibitor
except
psscl
sa
rapid
method
discoveri
select
cathepsin
substrat
report
substrat
develop
cathepsin
result
extens
sar
studi
individu
fluorogen
peptid
substrat
variat
one
posit
screen
panel
cathepsin
best
candid
select
optim
similar
proteas
develop
cathepsinspecif
inhibitor
mostli
reli
studi
peptid
peptidomimet
backbon
unprim
site
investig
electrophil
warhead
exampl
recent
review
one
classic
exampl
distinguish
cathepsin
optim
natur
broadspectrum
inhibitor
katunuma
colleagu
develop
sever
highli
select
cathepsin
b
cathepsin
l
inhibitor
replac
substitu
epoxid
electrophil
warhead
chang
nonprim
recognit
group
cathepsin
cathepsin
kspecif
inhibitor
develop
base
structur
leupeptin
pyridox
phosphat
respect
exampl
clearli
show
optim
lead
structur
mostli
broad
spectrum
inhibitor
excel
strategi
distinguish
close
relat
enzym
anoth
strategi
develop
potent
select
cathepsin
inhibitor
previous
mention
sa
best
substrat
convert
potent
inhibitor
replac
aminocoumarin
report
group
electrophil
pharmacophor
one
semin
exampl
cathepsin
probe
develop
ores
bender
et
al
nearinfrar
quenchedactivitybas
probe
becom
fluoresc
bound
cathepsin
activ
site
molecul
contain
fluorophor
attach
residu
peptidomimet
fragment
region
acyloxymethylketon
warhead
equip
bulki
quench
group
specif
probe
toward
cathepsin
test
vivo
vitro
model
demonstr
wide
rang
biolog
applic
legumain
asparaginyl
endopeptidas
cystein
proteas
upregul
inflammatori
diseas
multipl
human
cancer
legumain
also
activ
tumor
microenviron
thu
thought
promot
tumorigenesi
proteas
share
similar
previous
describ
proteas
group
caspas
cystein
cathepsin
analysi
tertiari
structur
legumain
assign
cd
clan
togeth
caspas
gingipain
separas
howev
local
enzym
mainli
lysosomalendosom
overlap
cystein
cathepsin
thu
specif
target
legumain
need
distinguish
proteas
caspas
cystein
cathepsin
howev
goal
challeng
legumain
display
narrow
specif
posit
recogn
asn
asp
residu
first
quench
activitybas
probe
specif
target
legumain
vivo
develop
bogyo
group
contain
threepeptid
scaffold
gluproasp
equip
acyloxymethylketon
warhead
flank
two
bulki
group
fluorophor
fluoresc
quencher
fig
gluproasp
prefer
motif
caspas
specif
obtain
sequenc
introduc
bulki
group
drive
cellular
uptak
lysosom
anoth
approach
distinguish
legumain
caspas
recent
propos
poreba
et
al
use
hycosul
author
demonstr
legumain
specif
posit
broad
toler
even
damino
acid
fig
thu
possibl
use
counter
select
extract
tetrapeptid
motif
asp
recogn
apoptot
caspas
motif
use
develop
legumainspecif
substrat
inhibitor
activitybas
probe
track
legumain
activ
variou
biolog
model
studi
provid
proof
principl
use
cosesul
approach
develop
specif
tool
proteas
display
broad
substrat
specif
human
genom
encod
approxim
dub
repres
human
proteas
enzym
also
display
similar
substrat
prefer
highthroughput
screen
one
success
strategi
appli
differenti
enzym
screen
compound
close
relat
ubiquitin
ctermin
hydrolas
enzym
allow
develop
inhibitor
base
isatin
oacyl
oxim
scaffold
anoth
approach
borodovski
colleagu
use
chemic
ligat
method
intein
strategi
c
terminu
ubiquitin
protein
modifi
differ
warhead
depend
type
warhead
probe
exhibit
level
specif
toward
differ
dub
anoth
approach
drag
et
al
use
psscl
identifi
precis
substrat
specif
three
human
dub
ovarian
tumor
isopeptidas
one
viral
ubiquitinspecif
proteas
papainlik
proteas
sever
acut
respiratori
syndrom
coronaviru
kinet
analysi
posit
reveal
differ
enzym
exploit
design
specif
substrat
candid
psscl
librari
approach
also
use
analyz
substrat
specif
human
desumoyl
enzym
sentrinspecif
proteas
senp
result
screen
librari
clearli
show
similar
substrat
specif
natur
amino
acid
posit
senp
design
specif
probe
dub
senp
remain
substanti
challeng
matrix
metalloproteinas
mmp
includ
member
zincdepend
endopeptidas
famili
metzincin
class
metalloendopeptidas
share
common
domain
structur
common
classif
mmp
base
histor
assess
catalyt
prefer
cellular
local
therefor
one
distinguish
four
group
mmp
collagenas
gelatinas
stromelysin
membranetyp
mmp
nevertheless
sever
mmp
classifi
tradit
group
mmp
initi
associ
cancer
progress
due
abil
degrad
connect
tissu
line
blood
vessel
cell
enzym
involv
wide
varieti
biolog
process
tissu
remodel
associ
angiogenesi
morphogenesi
tissu
repair
due
import
role
human
mmp
subject
precis
spatial
tempor
control
prevent
becom
destruct
last
year
mani
studi
focus
identifi
select
molecul
discrimin
mmp
applic
highthroughput
proteom
identif
proteas
cleavag
site
method
investig
primari
extend
substrat
specif
profil
mmp
use
biolog
divers
peptid
studi
allow
gener
specif
featur
share
mmp
determin
explor
featur
character
particular
mmp
howev
greatest
challeng
distinguish
mmp
abovement
group
well
group
abil
mmp
hydrolyz
similar
peptid
substrat
shown
chen
et
al
exhibit
overlap
substrat
recognit
could
distinguish
pocket
prefer
precis
kinet
studi
synthet
peptid
show
replac
one
amino
acid
residu
posit
convert
rel
select
substrat
substrat
find
underlin
signific
posit
suggest
subsit
interact
substrat
differ
ratnikov
et
al
compar
mmp
cleavag
yield
select
extend
set
phage
peptid
substrat
approxim
million
sequenc
quantifi
structurefunct
depend
eight
differ
mmp
repres
three
phylogenet
subfamili
chosen
proteas
includ
gelatinas
subfamili
transmembran
mmp
gpimmp
subfamili
contain
glycophosphatidyl
inositol
gpi
cell
surfac
anchor
calcul
secondord
rate
constant
k
ob
constitut
good
distanc
measur
function
similar
matrix
metalloproteinas
branch
base
patholog
role
mmp
diseas
attempt
made
identifi
drug
har
therapeut
potenti
mmp
inhibit
inhibitor
target
mmp
activ
develop
fail
clinic
trial
due
lack
specif
toward
target
enzym
preliminari
trial
develop
mmp
inhibitor
focus
compound
chelat
catalyt
zn
ion
possess
backbon
mimick
natur
peptid
substrat
individu
mmp
firstgener
mmp
inhibitor
compos
collagen
backbon
hydroxam
acid
c
nhoh
base
scaffold
sever
collagenbas
peptidomimet
hydroxam
develop
includ
ilomastat
marimastat
batimastat
batimastat
first
mmp
inhibitor
enter
clinic
trial
show
strong
inhibit
toward
ic
nm
ic
nm
ic
nm
ic
nm
howev
low
specif
observ
clinic
trial
disappoint
new
gener
hydroxamatebas
mmp
inhibitor
consist
substitut
aryl
sulfonamid
zincbind
group
propos
identifi
select
inhibitor
revers
hydroxam
nonhydroxam
inhibitor
develop
avoid
limit
associ
hydroxamatebas
inhibitor
metabol
inactiv
crossreact
metalloproteas
structur
mmp
reveal
crystallographi
next
gener
mmp
inhibitor
longer
restrain
substratelik
compound
new
molecul
divers
peptidomimet
nonpeptidomimet
scaffold
design
investig
numer
differ
structur
led
identif
select
mmp
inhibitor
exampl
thiolbas
inhibitor
compos
deeppocketbind
diphenyleth
scaffold
specif
inhibit
constant
k
nm
respect
due
high
structur
homolog
differ
member
mmp
famili
difficult
distinguish
enzym
recent
studi
turn
target
less
conserv
site
mmp
instead
previous
target
catalyt
site
mmp
like
proteolyt
enzym
possess
prime
nonprim
subsit
howev
pocket
import
site
substrat
recognit
thu
exhibit
greatest
degre
variabl
among
mmp
term
amino
acid
sequenc
pocket
shape
base
knowledg
number
pocketspecif
inhibitor
design
show
improv
select
anoth
trend
distinguish
member
mmp
famili
applic
antibodybas
therapeut
util
highli
select
potent
functionblock
antibodi
extrem
select
inhibitor
identifi
use
human
antibodi
phage
display
librari
autom
select
strategi
exampl
found
literatur
almost
previou
studi
focus
distinguish
mmp
constitut
use
start
point
futur
research
studi
mucha
et
al
use
unusu
amino
acid
improv
mmp
substrat
specif
provid
perspect
type
studi
aminopeptidas
exopeptidas
hydrolyz
one
two
amino
acid
residu
ntermin
fragment
substrat
enzym
belong
aminopeptidas
famili
share
sever
common
featur
import
catalyt
activ
highli
conserv
hexxh
x
zincbind
gamen
motif
recent
aminopeptidas
studi
use
select
substrat
gener
neglect
mainli
due
lack
specif
chemic
tool
gener
substrat
use
aminopeptidas
studi
classic
exampl
includ
alanin
leucin
substrat
use
famili
respect
aminopeptidas
fingerprint
approach
publish
drag
et
al
overcam
limit
led
first
scrupul
analysi
aminopeptidas
n
specif
fig
exampl
specif
peptid
sequenc
use
substrat
aminopeptidas
leukotrien
hydrolas
differ
speci
defin
fluorogen
librari
sequenc
nh
xacc
x
repres
amino
acid
residu
enrich
unnatur
amino
acid
deriv
appli
subsequ
librari
later
expand
addit
sever
new
deriv
appli
sever
aminopeptidas
human
organ
eg
bacteria
anim
plant
studi
led
gener
conclus
unnatur
amino
acid
prefer
aminopeptidas
natur
amino
acid
fig
moreov
approach
appli
distinguish
aminopeptidas
cell
lysat
provid
clear
inform
presenc
individu
aminopeptidas
previous
possibl
date
aminopeptidas
fingerprint
approach
use
unnatur
amino
acid
bestknown
method
distinguish
aminopeptidas
carboxypeptidas
enzym
respons
hydrolysi
ctermin
amino
acid
peptid
substrat
attribut
underli
particip
variou
essenti
biolog
process
date
known
repres
human
carboxypeptidas
peptidas
establish
carboxypeptidas
activ
report
merop
databas
classifi
chemic
natur
activ
site
therefor
one
distinguish
metallocarboxypeptidas
famili
serin
carboxypeptidas
famili
cystein
carboxypeptidas
famili
substrat
specif
numer
carboxypeptidas
determin
use
variou
techniqu
primarili
kinet
analys
synthet
substrat
biolog
relev
peptid
well
proteomederiv
peptid
librari
barinka
et
al
use
novel
assay
determin
hydrolyt
activ
recombin
human
glutam
carboxypeptidas
ii
base
fluorimetr
detect
releas
aamino
group
adopt
obtain
result
enzym
character
dipeptid
librari
synthes
via
solidphas
peptid
synthesi
action
pure
recombin
enzym
panel
dipeptid
test
releas
ctermin
amino
acid
residu
determin
fluorometr
util
opa
derivat
substrat
specif
carboxypeptidas
determin
similar
way
deiteren
et
al
differ
util
seri
benzoylxaaarg
substrat
long
fricker
colleagu
defin
enzymat
prefer
carboxypeptidas
first
time
use
overlap
strength
three
interdepend
approachesa
kinet
analysi
chromogen
substrat
individu
cleavag
synthet
peptid
quantit
peptidom
mass
spectrometrybas
approach
date
mani
studi
carboxypeptidas
substrat
specif
found
literatur
one
enzym
catalyt
activ
ubiquitinproteasom
system
play
pivot
role
control
degrad
protein
eukaryot
cell
proteolyt
action
regulatori
protein
make
one
import
enzym
system
involv
almost
biolog
process
includ
cell
develop
differenti
proteolysi
substrat
occur
within
proteasom
core
particl
barrelshap
protein
complex
contain
four
stack
ring
compos
seven
subunit
seven
b
subunit
uniqu
three
subunit
possess
catalyt
threonin
residu
requir
proteolyt
cleavag
subunit
date
studi
conduct
harri
et
al
import
provid
primari
knowledg
substrat
specif
individu
proteasom
subunit
primari
ntermin
extend
substrat
specif
human
proteasom
defin
presenc
proteasom
activ
use
comprehens
composit
set
fluorogen
substrat
data
promot
full
character
proteasom
activ
dissect
proteolyt
effect
individu
proteasom
subunit
inform
essenti
design
specif
substrat
inhibitor
approach
constitut
power
tool
determin
nonprim
residu
peptid
substrat
method
employ
examin
primesid
substrat
specif
exampl
lesner
et
al
employ
combinatori
chemistri
intern
quench
fluoresc
peptid
substrat
synthes
peptid
substrat
optim
prime
nonprim
region
peptid
chain
approach
use
determin
trypsinlik
subunit
substrat
specif
select
best
substrat
abzvalvalserargserleuglytyr
nh
k
cat
k
abzvalvalsergnfalametglytyr
nh
k
cat
k
show
signific
select
differ
proteasom
unit
later
lesner
group
investig
chymotrypsinlik
activ
proteasom
subunit
identifi
select
substrat
abzvalvalsertyralametglytyr
nh
determin
kinet
paramet
k
cat
k
k
cat
first
studi
chymotrypsinlik
activ
alon
lead
optim
prime
area
substrat
avoid
nonselect
process
proteas
overlap
specif
mani
natur
synthet
compound
inhibit
protein
degrad
proteasom
natur
inhibitor
includ
lactacystin
epoxyketon
cyclic
peptid
first
synthet
compound
report
inhibit
proteasom
activ
peptid
aldehyd
zleuleuleu
zileglu
obut
alaleu
psi
peptid
vinyl
sulfon
compound
bind
activ
site
within
core
particl
howev
reactiv
compound
mani
drawback
includ
lack
specif
toward
individu
proteasom
activ
subunit
addit
compound
also
known
inhibit
serin
cystein
proteas
eg
calpain
cathepsin
therefor
would
inadvis
use
compound
drug
date
three
import
proteasom
inhibitor
approv
drug
bortezomib
carfilzomib
ixazomib
three
preferenti
bind
subunit
respons
chymotrypsinlik
activ
proteasom
also
inhibit
caspaseand
trypsinlik
proteolyt
site
higher
dose
g
de
bruin
colleagu
report
signific
attempt
distinguish
particular
proteasom
subunit
base
previou
studi
group
present
set
abp
promot
gelbas
detect
catalyt
human
proteasom
subunit
also
develop
specif
inhibitor
individu
proteasom
activ
recent
bogyo
group
design
inhibitor
base
amino
acid
prefer
specif
plasmodium
falciparum
human
proteasom
eleg
work
show
proteasom
ortholog
distinguish
use
natur
amino
acid
case
bulki
tryptophan
key
amino
acid
human
proteasom
show
chymotrypsinlik
bulki
amino
acid
trypsinlik
basic
amino
acid
caspaselik
acid
asp
activ
wherea
p
falciparum
proteasom
prefer
aromat
trp
pocket
knowledg
proteas
increas
dramat
year
tabl
howev
studi
typic
restrict
one
particular
group
enzym
individu
enzym
due
lack
specif
substrat
inhibitor
abp
sever
year
mani
studi
attempt
identifi
specif
molecul
act
differ
enzym
similar
substrat
prefer
fig
number
modern
design
techniqu
appli
identifi
proteasespecif
sequenc
includ
phage
display
psscl
clip
proteom
howev
method
limit
natur
amino
acid
alway
suffici
distinguish
close
relat
enzym
caspas
neutrophil
serin
proteas
aminopeptidas
cathepsin
recent
describ
hycosul
cosesul
techniqu
incorpor
broad
rang
unnatur
structur
current
method
choic
distinguish
enzym
similar
substrat
specif
success
target
chemic
tool
possess
natur
amino
acid
